Rep. Sensenbrenner Reintroduces the Safe RESEARCH Act to Prohibit the Sale of Fetal Tissue
"This legislation is an important step forward in the ongoing efforts to protect innocent lives and fight on behalf of the unborn."
WASHINGTON, D.C. – Today, Congressman Jim Sensenbrenner reintroduced legislation to prohibit the sale of fetal tissue acquired by performing an abortion.
The Safe Responsible, Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare (RESEARCH) Act would amend Section 498A of the Public Health Act to state that human fetal tissue may be used for research purposes, but only if it is obtained as a result of a stillbirth or ectopic pregnancy, not from an abortion procedure.
Not only is harvesting and selling fetal tissue a gruesome and horrific process, advancements in medical technology, such as adult stem cell science, has rendered fetal tissue an unnecessary option for medical researchers. The Safe RESEARCH Act would help end this practice and take another important step forward in protecting the lives of our nation’s most vulnerable citizens.
Congressman Sensenbrenner: “Due to a poorly drafted section of federal law, Planned Parenthood and other abortion clinics throughout the country are legally able to sell fetal tissue to research institutions. This despicable practice is morally bankrupt, victimizes the defenseless, and increases profits for organizations that have no regard for human life. This legislation is an important step forward in the ongoing efforts to protect innocent lives and fight on behalf of the unborn.”
Earlier this month, the Family Research Council announced Congressman Sensenbrenner received a perfect score during the 114th Congress on its annual Vote Scorecard for Members of Congress who demonstrate an unwavering commitment to the protection of unborn children.